Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124180842 | 12418084 | 2 | F | 20160412 | 20160630 | 20160531 | 20160712 | EXP | IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-039487 | BRISTOL MYERS SQUIBB | 81.75 | YR | M | Y | 0.00000 | 20160712 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124180842 | 12418084 | 1 | PS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | 1 U, PRN | U | 9218 | 1 | DF | TABLET | ||||||
| 124180842 | 12418084 | 2 | SS | TACHIDOL | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Oral | 3 U, QD | 183 | DF | U | 0 | 3 | DF | QD | ||||
| 124180842 | 12418084 | 3 | SS | LANOXIN | DIGOXIN | 1 | Oral | 1 U, QD | 13.165 | MG | U | 0 | 1 | DF | QD | ||||
| 124180842 | 12418084 | 4 | C | FELODIPINE. | FELODIPINE | 1 | Oral | U | 0 | ||||||||||
| 124180842 | 12418084 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 25 MG, UNK | U | 0 | 25 | MG | |||||||
| 124180842 | 12418084 | 6 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | U | 0 | ||||||||||
| 124180842 | 12418084 | 7 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | Transdermal | 1 UNIT, UNK | U | 0 | 1 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124180842 | 12418084 | 1 | Atrial fibrillation |
| 124180842 | 12418084 | 2 | Product used for unknown indication |
| 124180842 | 12418084 | 3 | Product used for unknown indication |
| 124180842 | 12418084 | 4 | Product used for unknown indication |
| 124180842 | 12418084 | 5 | Product used for unknown indication |
| 124180842 | 12418084 | 6 | Product used for unknown indication |
| 124180842 | 12418084 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124180842 | 12418084 | OT |
| 124180842 | 12418084 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124180842 | 12418084 | Accidental overdose | |
| 124180842 | 12418084 | Asthenia | |
| 124180842 | 12418084 | Decreased appetite | |
| 124180842 | 12418084 | Dysstasia | |
| 124180842 | 12418084 | Psychomotor skills impaired | |
| 124180842 | 12418084 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124180842 | 12418084 | 1 | 20160101 | 20160512 | 0 | |
| 124180842 | 12418084 | 2 | 20160212 | 20160512 | 0 | |
| 124180842 | 12418084 | 3 | 20160101 | 20160512 | 0 |